GIANCIPOLI, Ermete
 Distribuzione geografica
Continente #
NA - Nord America 559
EU - Europa 260
AS - Asia 209
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 2
Totale 1.038
Nazione #
US - Stati Uniti d'America 553
CN - Cina 141
UA - Ucraina 105
SG - Singapore 58
IT - Italia 52
DE - Germania 38
SE - Svezia 25
BE - Belgio 12
FI - Finlandia 8
GB - Regno Unito 6
AU - Australia 5
CA - Canada 5
FR - Francia 5
CZ - Repubblica Ceca 3
EU - Europa 3
BR - Brasile 2
IR - Iran 2
KR - Corea 2
AT - Austria 1
BD - Bangladesh 1
CH - Svizzera 1
IE - Irlanda 1
IL - Israele 1
IN - India 1
IQ - Iraq 1
JP - Giappone 1
MD - Moldavia 1
MX - Messico 1
PL - Polonia 1
RO - Romania 1
TR - Turchia 1
Totale 1.038
Città #
Chandler 193
Jacksonville 61
Singapore 43
Princeton 42
Ann Arbor 32
Nanjing 27
Sassari 20
Dearborn 18
Wilmington 18
Shenyang 17
Beijing 14
New York 14
Brussels 12
Jinan 11
Tianjin 10
Ashburn 8
Cagliari 8
Hebei 8
Nanchang 8
Guangzhou 7
Boardman 5
Changsha 5
Falls Church 5
Mountain View 5
Carlingford 4
Jiaxing 4
Ningbo 4
San Mateo 4
Santa Clara 4
Toronto 4
Andover 3
Brno 3
Hangzhou 3
Munich 3
Norwalk 3
Paris 3
Quartu Sant'elena 3
Selargius 3
Augusta 2
Brescia 2
Foshan 2
Haikou 2
Seoul 2
Shijiazhuang 2
Torino 2
Vancouver 2
Zhengzhou 2
Alberobello 1
Baghdad 1
Belo Horizonte 1
Bom Jesus da Lapa 1
Chicago 1
Chisinau 1
Denver 1
Dhaka 1
Dublin 1
Iasi 1
Lanzhou 1
Montreal 1
Qinzhou 1
Raleigh 1
Redmond 1
Redwood City 1
Romola 1
Ronchis 1
San Francisco 1
Secaucus 1
Shaoxing 1
Sora 1
Taizhou 1
Tel Aviv 1
Treviso 1
Veracruz 1
Vienna 1
Woodbridge 1
Wuyuan 1
Xi'an 1
Zurich 1
Totale 688
Nome #
Management of macular oedema in diabetic patients undergoing cataract surgery 79
Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency and Late-stage Age-Related Macular Degeneration 76
Combined Phacoemulsification and Intravitreal Dexamethasone Implant (Ozurdex®) in Diabetic Patients with Coexisting Cataract and Diabetic Macular Edema 60
Dexamethasone intravitreal implant combined with anti-VEGF in patients with neovascular age related macular degeneration resistant to anti-VEGF alone 59
Retinal Break 57
IOL accomodative: principi di funzionamento 56
Morphologic and functional outcomes of different optical coherence tomography patterns of myopic foveoschisis after vitrectomy and inner limiting membrane peeling 56
Spectral-domain optical coherence tomography and fluorescein angiography features of cystoid macular edema with serous retinal detachment secondary to intracameral cefuroxime administration 55
Study of macular and optic disk blood flow by angio‐OCT in Glucose‐6‐Phosphate Dehydrogenase (G6PD) deficient men and age‐related G6PD‐normal subjects 55
Detection of serum uric acid in primary open angle glaucoma: A pilot study 55
Management of intra-operative complication during scleral buckling surgery - Francesco Boscia, Ermete Giancipoli, Giuseppe D'Amico Ricci, Giancarlo Sborgia 52
Gentle endodiathermy of retinal vessels to mark paravascular posterior retinal breaks in highly myopic eyes 50
Dexamethasone implant with fixed or individualized regimen in the treatment of diabetic macular oedema: Six-month outcomes of the UDBASA study 50
Real-world outcomes of non-responding diabetic macular edema treated with continued anti-VEGF therapy versus early switch to dexamethasone implant: 2-year results 49
Intravitreal dexamethasone in patients with wet age-related macular degeneration resistant to anti-VEGF: A prospective pilot study 48
Twenty-Five Gauge Vitrectomy for Myopic Foveoschisis 48
Twenty-Five Gauge Vitrectomy for Myopic Foveoschisis: Results at 6 months 42
Inverted internal limiting membrane-flap technique for large macular hole: a microperimetric study 39
Long-term capillary changes in areas of dissociated optic nerve fibre layer after macular hole surgery 35
G6PD-Carenza e degenerazione maculare legata all'età 33
Shall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edema 24
Real-World Outcomes of a Loading Phase with Intravitreal Faricimab in Neovascular Age-Related Macular Degeneration (n-AMD) and Diabetic Macular Edema (DME) 4
Totale 1.082
Categoria #
all - tutte 5.751
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.751


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020131 0 0 0 0 19 14 50 3 16 9 19 1
2020/2021162 20 3 23 1 19 4 23 5 24 34 4 2
2021/2022134 10 1 1 8 4 2 4 11 8 11 19 55
2022/2023295 25 39 6 68 18 49 0 26 37 0 17 10
2023/202476 14 3 1 5 18 6 0 9 0 2 4 14
2024/202596 2 6 32 29 27 0 0 0 0 0 0 0
Totale 1.082